ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 408,64
-0,30%
Dow Jones
42 297,12
0,86%
DAX
20 132,85
-0,44%
Brent Oil
80,28
0,00%
Bitcoin
94 558,37
0,05%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. F star Therapeutics Inc (FSTX) Cours

F star Therapeutics Inc

F star Therapeutics Inc (FSTX)

NASDAQ
7,12
0,00
(0,00%)
À la fermeture: 14 Janvier 10:00PM
Retardé de 15 minutes
7,12
0,00
( 0,00% )
Après les heures de négociation: -
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
7,12
Prix Achat
7,20
Prix Vente
7,72
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
7,12
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

FSTX Dernières nouvelles

Plus de nouvelles

F-star Announces Issuance of U.S. Patent Protecting FS118, a Bispecific Antibody Targeting PD-L1 and LAG-3

Provides U.S. Patent Protection to at least August 2038 Expands Patent Protection for FS118 Composition of Matter beyond Europe CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 20, 2022...

20 Janvier 2022
GlobeNewswire Inc.

F-star Therapeutics to Participate in Upcoming Investor Conferences

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

07 Janvier 2022
GlobeNewswire Inc.

F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

05 Janvier 2022
GlobeNewswire Inc.

F-star Therapeutics to Present FS222 Trial-in-Progress Update at ESMO Immuno-Oncology Congress 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Dec. 07, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

07 Décembre 2021
GlobeNewswire Inc.

F-star Therapeutics to Host Virtual R&D Day on December 6, 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

29 Novembre 2021
GlobeNewswire Inc.

F-star Therapeutics to Present at The Society for Immunotherapy of Cancer (SITC) 2021 Conference

Dr. Michelle Morrow to present on F-star’s Proprietary Bispecific Platform including FS118, our LAG-3/PD-L1 Bispecific Poster Presentation of Preclinical Data Demonstrates Potential for F-star’s...

12 Novembre 2021
GlobeNewswire Inc.

F-star Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Company to Host Conference Call Today at 9 a.m. EST CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) --  F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage...

10 Novembre 2021
GlobeNewswire Inc.

F-star Therapeutics to Announce Third Quarter Results and Host Conference Call on November 10, 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

01 Novembre 2021
GlobeNewswire Inc.

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Oct. 20, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Ltd. (NASDAQ: FSTX) (“F-star” or the “Company”), a clinical-stage biopharmaceutical company...

20 Octobre 2021
GlobeNewswire Inc.

F-star Therapeutics to Present FS120 Phase 1 Trial-in-Progress Update at ESMO 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Sept. 16, 2021 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...

16 Septembre 2021
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

FSTX - Frequently Asked Questions (FAQ)

What is the current F star Therapeutics share price?
The current share price of F star Therapeutics is US$ 7,12
What is the 1 year trading range for F star Therapeutics share price?
F star Therapeutics has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
YOSHYoshiharu Global Company
US$ 4,2336
(47,00%)
89,29k
STAFStaffing 360 Solutions Inc
US$ 3,30
(45,05%)
2,09M
MNDRMobile health Network Solutions
US$ 0,5628
(38,55%)
16,78M
AREBAmerican Rebel Holdings Inc
US$ 2,6599
(23,72%)
217,82k
PIIIP3 Partners Inc
US$ 0,252
(17,26%)
10,47M
ATPCAgape ATP Corporation
US$ 1,60
(-18,78%)
520,41k
CHEKCheck Cap Ltd
US$ 1,24
(-17,33%)
69,47k
AEHRAehr Test Systems
US$ 13,40
(-16,20%)
789,46k
GCTKGlucoTrack Inc
US$ 0,1268
(-15,30%)
19,05M
RZLVRezolve AI Ltd
US$ 2,0498
(-14,59%)
643,35k
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0683
(8,59%)
23,41M
GCTKGlucoTrack Inc
US$ 0,1268
(-15,30%)
19,05M
MNDRMobile health Network Solutions
US$ 0,5628
(38,55%)
16,78M
LAESSEALSQ Corporation
US$ 2,99
(-10,75%)
12,2M
PIIIP3 Partners Inc
US$ 0,252
(17,26%)
10,47M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
FSTX
F star Therapeutics
NASDAQ
ABMNGXX
Jpmorgan Chase Financial...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés